A director at Salter Brothers Emerging Companies Ltd bought 90,636 shares at 0.651AUD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
A director at 1&1 Drillisch Ag bought 4,400,000 shares at 13.815EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
MYT Netherlands Parent B.V. (“Mytheresa”) receives final regulatory clearance to acquire YOOX NET-A-PORTER (“YNAP”) from Richemont, with closing planned for 23 April 2025 MYT Netherlands Parent B.V. (“Mytheresa”) receives final regulatory clearanceto acquire YOOX NET-A-PORTER (“YNAP”) from Richemont, with closing planned for 23 April 2025 11 April 2025 – Today, Mytheresa (NYSE:MYTE) received the unconditional merger control clearance from the European Commission for the acquisition of YNAP from Richemont (SWX:CFR), through its subsidiary Richemont Italia Holding S.P.A.. Mytheresa a...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Aviva plc 11-Apr-2025 / 14:23 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlo...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated 11-Apr-2025 / 14:25 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the truste...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc 11-Apr-2025 / 14:23 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the tr...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. 11-Apr-2025 / 14:24 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. ...
Apex Fundrock Limited (MISL) Form 8.3 - Induction Healthcare Group PLC - Opening Position Disclosure 11-Apr-2025 / 14:27 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Chelverton Asset Management (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a ...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Assura plc 11-Apr-2025 / 14:24 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settl...
Middlefield Canadian Income PCC: Net Asset Value(s) Middlefield Canadian Income PCC Net Asset Value Middlefield Canadian Income PCC Middlefield Canadian Income - GBP PC (a protected cell company incorporated in Jersey with registration number 93546)Legal Entity Identifier: 2138007ENW3JEJXC8658 Net Asset Value As at the close of business on 10 April 2025 the estimated unaudited Net Asset Value per share was 116.36 pence (including accrued income), which excludes an amount of 1.375 pence per share in respect of the quarterly dividend to be paid on 30 April 2025. Investments in the Compa...
A director at Calida Holding AG bought 1,000 shares at 16.520CHF and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements - The universal oxygen carrier delivery capabilities of BXT-25 can be monitored, broadening its applications to treat hypoxic diseases - Leading drug candidate ProLectin-M targets galectins in viral infections including bird flu like viruses BOSTON, MASSACHUSETTS, April 11, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing novel therapies targeting hypoxia and mitochondrial dysfunction, today highlighted the historical and scientific signifi...
Sify Technologies to announce Financial Results for FY 2024-25 on April 18, 2025 CHENNAI, India, April 11, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced that it will report its unaudited IFRS financial results for the full year ended March 31, 2025 on Friday, April 18, 2025. The following Monday, April 21, 2025, Sify will host a conference call at 8:30 AM ET with Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, E...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc 11-Apr-2025 / 14:22 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Intern viden: Conferize A/S investerer i Sophos Evolution Ltd Selskabsmeddelelse nr. 7/2025København, den 11. april 2025 Conferize A/S har indgået aftale om at erhverve 7,74% af aktiekapitalen i det engelske selskab Sophus Evolution Ltd. Derudover er der erhvervet konvertible lån for DKK 1,1 mio. til selskabet. Den samlede pris for erhvervelsen er DKK 1,5 mio. Betalingen sker ved udstedelse af et 24 måneders konvertibelt gældsbrev med en konverteringskurs på DKK 0,02 pr. aktie. Sophos Evolution er en ny aktør inden for generativ kunstig intelligens og har udviklet en række brugerven...
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance ATLANTA, April 11, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders, today announced that it has received written confirmation from Nasdaq that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2.5 million. DWTX Chairman and CEO Greg Duncan stated, “We are pleased that the Company successfully impl...
Freight Technologies Announces AI Lab to Enhance Cross-Border Freight Logistics AI Lab to enable smarter freight operations for customers by developing and integrating cognitive AI solutions Freight Technologies has established a strategic collaboration with the University of Monterrey’s AI Program to advance AI-powered logistics innovation HOUSTON, April 11, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: FRGT, “Fr8Tech” or the “Company”), a logistics management innovation company, offering a diverse portfolio of technology-driven solutions, proudly announces the launch of its AI Lab, a pio...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.